0001144204-19-001143.txt : 20190108 0001144204-19-001143.hdr.sgml : 20190108 20190108195110 ACCESSION NUMBER: 0001144204-19-001143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190108 FILED AS OF DATE: 20190108 DATE AS OF CHANGE: 20190108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boothe Douglas CENTRAL INDEX KEY: 0001566118 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32360 FILM NUMBER: 19517055 MAIL ADDRESS: STREET 1: C/O IMPAX LABORATORIES, INC. STREET 2: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKORN INC CENTRAL INDEX KEY: 0000003116 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 720717400 STATE OF INCORPORATION: LA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1925 W. FIELD COURT, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 847-279-6100 MAIL ADDRESS: STREET 1: 1925 W. FIELD COURT, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 4 1 tv510640_4.xml OWNERSHIP DOCUMENT X0306 4 2019-01-08 0 0000003116 AKORN INC AKRX 0001566118 Boothe Douglas C/O AKORN, INC. 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 0 1 0 0 President and CEO Common Stock 2019-01-08 4 A 0 507614 0 A 507614 D Stock Options (Right to Buy) 3.94 2019-01-08 4 A 0 405938 0 A 2029-01-08 Common Stock 405938 405938 D Performance Share Units 2019-01-08 4 A 0 253807 0 A Common Stock 253807 253807 D The securities acquired are Restricted Stock Units (RSUs) scheduled to vest in four equal installments on January 8, 2020, January 8, 2021, January 8, 2022 and January 8, 2023. The Stock Options vest in four equal installments on January 8, 2020, January 8, 2021, January 8, 2022 and January 8, 2023. Each Performance Share Unit (PSU) represents a contingent right to receive one share of Akorn common stock. The PSUs will vest at the end of a four-year performance period on January 7, 2023 at between 0% and 300% of target based upon the achievement of a specified price of Akorn's common stock (from $8 to $20), subject to continued service through the date of settlement. /s/ Joseph Bonaccorsi, Attorney-in-Fact 2019-01-08